secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2024-01-19T23:59:59+00:00
Accession:  0001824293-24-000018
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio stockholders approve reverse stock split; range 1:2 to 1:9
------------------------------------------------------------------

- Special meeting held Jan 19, 2024; quorum of 1,977,444 shares (43.7%) present.
- Reverse split proposal approved: 1,158,012 for, 817,185 against.
- Adjournment proposal approved: 1,252,187 for, 716,895 against.
- Board may set exact ratio within 1:2 to 1:9 and can abandon the split.
- No reduction in authorized shares; exact ratio and timing at board's discretion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000018/0001824293-24-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000018/val-20240119.htm
  HTML page:      https://secwatch.observer/filing/0001824293-24-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer